• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

目前关于首发静脉血栓形成的遗传学知识。

Current knowledge on the genetics of incident venous thrombosis.

机构信息

INSERM, UMR_S1062, Nutrition Obesity and Risk of Thrombosis, Aix-Marseille University, Marseille, France.

出版信息

J Thromb Haemost. 2013 Jun;11 Suppl 1:111-21. doi: 10.1111/jth.12233.

DOI:10.1111/jth.12233
PMID:23809115
Abstract

The genetic burden underlying venous thrombosis (VT) is characterized by a sibling relative risk of 2.5 and a strong heritability whose estimates varied from 35% to 60% according to different studies. However, the genetic factors identified so far only explain about 5% of VT heritability and just 16 genes have been robustly associated with the susceptibility to VT, most of them affecting the coagulation cascade. Eight of these have been identified during the last 5 years, thanks to the development of high-throughput micro-array genotyping technologies, which have radically changed the research landscape in human genetics. The present work is aimed at providing a historical review of the known genetic factors contributing to VT risk, as well as discussing future research strategies to follow to disentangle the whole spectrum of genetic variants associated with VT.

摘要

静脉血栓形成(VT)的遗传负担的特点是兄弟姐妹相对风险为 2.5,且具有很强的遗传性,根据不同的研究,其估计值从 35%到 60%不等。然而,迄今为止发现的遗传因素仅能解释约 5%的 VT 遗传性,并且仅有 16 个基因与 VT 的易感性显著相关,其中大多数基因影响凝血级联反应。在过去的 5 年中,由于高通量微阵列基因分型技术的发展,已经确定了其中的 8 个基因,这些技术从根本上改变了人类遗传学的研究格局。本工作旨在对已知的遗传因素进行历史回顾,这些因素导致 VT 风险,并讨论未来的研究策略,以阐明与 VT 相关的所有遗传变异体。

相似文献

1
Current knowledge on the genetics of incident venous thrombosis.目前关于首发静脉血栓形成的遗传学知识。
J Thromb Haemost. 2013 Jun;11 Suppl 1:111-21. doi: 10.1111/jth.12233.
2
Genetics of Venous Thrombosis: update in 2015.静脉血栓形成的遗传学:2015年更新
Thromb Haemost. 2015 Nov;114(5):910-9. doi: 10.1160/TH15-05-0410. Epub 2015 Sep 10.
3
Genetics of venous thrombosis: insights from a new genome wide association study.静脉血栓形成的遗传学:一项新的全基因组关联研究的启示。
PLoS One. 2011;6(9):e25581. doi: 10.1371/journal.pone.0025581. Epub 2011 Sep 27.
4
Identification of a Plasma MicroRNA Profile Associated With Venous Thrombosis.鉴定与静脉血栓形成相关的血浆 microRNA 谱。
Arterioscler Thromb Vasc Biol. 2020 May;40(5):1392-1399. doi: 10.1161/ATVBAHA.120.314092. Epub 2020 Mar 12.
5
Genetics of venous thrombosis.静脉血栓形成的遗传学
J Thromb Haemost. 2009 Jul;7 Suppl 1:301-4. doi: 10.1111/j.1538-7836.2009.03394.x.
6
Genetic risk factors for venous thrombosis in the elderly in a case-control study.老年静脉血栓形成的遗传危险因素:病例对照研究。
J Thromb Haemost. 2016 Sep;14(9):1759-64. doi: 10.1111/jth.13409. Epub 2016 Aug 26.
7
Genetic variations and their influence on risk and treatment of venous thrombosis.基因变异及其对静脉血栓形成风险和治疗的影响。
Pharmacogenomics. 2008 Apr;9(4):423-37. doi: 10.2217/14622416.9.4.423.
8
A follow-up study of a genome-wide association scan identifies a susceptibility locus for venous thrombosis on chromosome 6p24.1.一项全基因组关联扫描的随访研究确定了染色体 6p24.1 上静脉血栓形成的易感性位点。
Am J Hum Genet. 2010 Apr 9;86(4):592-5. doi: 10.1016/j.ajhg.2010.02.011. Epub 2010 Mar 11.
9
Genetic risk factors of venous thrombosis.静脉血栓形成的遗传风险因素。
Hum Genet. 2001 Oct;109(4):369-84. doi: 10.1007/s004390100593.
10
Protein S Heerlen mutation heterozygosity is associated with venous thrombosis risk.蛋白 S 海勒姆突变杂合性与静脉血栓形成风险相关。
Sci Rep. 2017 Apr 4;7:45507. doi: 10.1038/srep45507.

引用本文的文献

1
Joint effects of atrial fibrillation and prothrombotic genotypes on the risk of venous thromboembolism.心房颤动和血栓形成前基因型对静脉血栓栓塞风险的联合影响。
Res Pract Thromb Haemost. 2025 May 8;9(4):102880. doi: 10.1016/j.rpth.2025.102880. eCollection 2025 May.
2
Gut microbiota, plasma metabolites, and venous thromboembolism: a Mendelian randomization study.肠道微生物群、血浆代谢物与静脉血栓栓塞:一项孟德尔随机化研究
AMB Express. 2025 Jun 20;15(1):97. doi: 10.1186/s13568-025-01903-8.
3
Increased Platelet Adhesiveness in Patients with Venous Thromboembolic Disease.
静脉血栓栓塞性疾病患者血小板黏附性增加。
TH Open. 2024 Nov 30;8(4):e329-e339. doi: 10.1055/s-0044-1800798. eCollection 2024 Oct.
4
Fibrinolysis biomarker, thrombin, and activated protein C level alterations after coagulation activation depend on type of thrombophilia and clinical phenotype.凝血激活后纤维蛋白溶解生物标志物、凝血酶和活化蛋白C水平的改变取决于血栓形成倾向的类型和临床表型。
Res Pract Thromb Haemost. 2024 Feb 15;8(2):102351. doi: 10.1016/j.rpth.2024.102351. eCollection 2024 Feb.
5
Elevated plasma complement factor H related 5 protein is associated with venous thromboembolism.血浆补体因子 H 相关蛋白 5 升高与静脉血栓栓塞相关。
Nat Commun. 2023 Jun 7;14(1):3280. doi: 10.1038/s41467-023-38383-y.
6
Proteomics in thrombosis research.血栓形成研究中的蛋白质组学
Res Pract Thromb Haemost. 2022 Apr 25;6(3):e12706. doi: 10.1002/rth2.12706. eCollection 2022 Mar.
7
Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk.复方口服避孕药与静脉血栓栓塞症:风险减轻的回顾与展望。
Front Endocrinol (Lausanne). 2021 Dec 9;12:769187. doi: 10.3389/fendo.2021.769187. eCollection 2021.
8
The recombinant plant Bauhinia bauhinioides elastase inhibitor reduces rat thrombus without alterations in hemostatic parameters.重组植物羊蹄甲弹性蛋白酶抑制剂可减少大鼠血栓形成,而不改变止血参数。
Sci Rep. 2021 Jun 29;11(1):13475. doi: 10.1038/s41598-021-92745-4.
9
Implications of venous thromboembolism GWAS reported genetic makeup in the clinical outcome of ovarian cancer patients.静脉血栓栓塞症 GWAS 报道的遗传构成与卵巢癌患者的临床结局相关。
Pharmacogenomics J. 2021 Apr;21(2):222-232. doi: 10.1038/s41397-020-00201-9. Epub 2020 Nov 7.
10
Genetic association study of fatal pulmonary embolism.致命性肺栓塞的遗传关联研究。
Int J Legal Med. 2021 Jan;135(1):143-151. doi: 10.1007/s00414-020-02441-7. Epub 2020 Oct 30.